agilon health Inc.
07/22/2026 | Press release | Distributed by Public on 07/22/2026 04:01
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 17, 2026, agilon health, inc. (the "Company") provided notice to Girish Venkatachaliah, the Company's Chief Technology Officer, that Mr. Venkatachaliah's employment with the Company will terminate effective August 1, 2026 (the "Separation Date"). In connection with Mr. Venkatachaliah's separation from employment, the Company provided Mr. Venkatachaliah with a Severance Agreement and General Release (the "Severance Agreement") which will become effective eight days following Mr. Venkatachaliah's execution of the Severance Agreement. Concurrently, the Company and Mr. Venkatachaliah intend to enter into a Consulting Agreement (the "Consulting Agreement") effective as of August 1, 2026 and pursuant to which Mr. Venkatachaliah will provide the Company with transition consulting services through December 31, 2026 for no consideration other than the continued equity award vesting referenced below.
The Severance Agreement provides that Mr. Venkatachaliah will be entitled to receive severance benefits consisting of cash severance totaling $766,063.00 (to be paid in installments over twelve months following the Separation Date), as well as continued vesting through April 30, 2027 (as though Mr. Venkatachaliah had remained employed with the Company through that date, and subject to any applicable performance-based vesting requirements) of the transformation equity award granted by the Company to Mr. Venkatachaliah in 2025 as well as the other outstanding time/service-vesting restricted stock unit awards previously granted by the Company to Mr. Venkatachaliah that are scheduled to vest on or before April 30, 2027.
The foregoing summary of the Severance Agreement, including the Consulting Agreement attached thereto, does not purport to be complete and is qualified in its entirety by reference to the full text of such agreements, which are filed as Exhibit 10.1 hereto and incorporated herein by reference.
agilon health Inc. published this content on July 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 22, 2026 at 10:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]